Medicinova (MNOV) Posts Narrower than Expected Q4 Loss of 22c/Share

Medicinova, Inc. (NASDAQ: MNOV) reported Q4 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Medicinova, Inc. (MNOV) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral